1 Executive Summary
1.1 Market Attractiveness Analysis 15
1.1.1 Global Perfusion Imaging Market, By Modality 15
1.1.2 Global Perfusion Imaging Market, By Application 16
2 Market Introduction
2.1 Definition 17
2.2 Scope Of The Study 17
2.3 Assumptions & Limitations 17
2.3.1 Assumptions 17
2.3.2 Limitations 17
2.4 Market Structure 18
3 Research Methodology
3.1 Research Process 19
3.2 Primary Research 20
3.3 Secondary Research 21
3.4 Market Size Estimation 21
3.5 Forecast Model 22
4 Market Dynamics
4.1 Overview 23
4.2 Drivers 24
4.2.1 Growing Prevalence Of Cardiovascular And Neurological Diseases 24
4.2.2 Increasing Geriatric Population 24
4.2.3 Advancements In Technology 24
4.3 Restraints 25
4.3.1 Stringent Regulatory Policies 25
4.3.2 Lack Of Awareness For The Use Of Advanced Technologies 25
4.4 Opportunities 26
4.4.1 Entering Developing Economies 26
4.5 Macroeconomic Indicators 26
5 Market Factor Analysis
5.1 Value Chain Analysis 27
5.1.1 R&D And Designing 27
5.1.2 Manufacturing 27
5.1.3 Packaging & Assembly 27
5.1.4 Distribution & Sales 28
5.1.5 Post-Sales Review 28
5.2 Porter’s Five Forces Analysis 29
5.2.1 Bargaining Power Of Suppliers 29
5.2.2 Bargaining Power Of Buyers 29
5.2.3 Threat Of New Entrants 30
5.2.4 Threat Of Substitutes 30
5.2.5 Intensity Of Rivalry 30
6 Perfusion Imaging Market, By Modality
6.1 Overview 31
6.2 Computed Tomography (CT Scan) 32
6.3 Magnetic Resonance Imaging (MRI) 33
6.4 Nuclear Medicine 34
7 Perfusion Imaging Market, By Application
7.1 Overview 35
7.2 Myocardial Perfusion Imaging 36
7.3 Ventilation Perfusion Imaging 37
7.4 Functional Brain Imaging 38
8 Global Perfusion Imaging Market, By Region
8.1 Overview 39
8.2 Americas 41
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.2.1 North America 43
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.2.1.1 US 44
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.2.1.2 Canada 45
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.2.2 Latin America 46
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.3 Europe 47
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.3.1 Western Europe 48
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.3.1.1 Germany 50
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.3.1.2 France 50
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.3.1.3 UK 51
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.3.1.4 Italy 52
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.3.1.5 Spain 52
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.3.1.6 Rest Of Western Europe 53
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.3.2 Eastern Europe 54
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.4 Asia-Pacific 55
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.4.1.1 Japan 56
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.4.1.2 China 57
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.4.1.3 India 58
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.4.1.4 South Korea 58
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.4.1.5 Australia 59
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.4.1.6 Rest Of Asia-Pacific 60
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.5 Middle East & Africa 61
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.5.1 Middle East 62
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
8.5.2 Africa 63
Perfusion Imaging Market, By Modality
Perfusion Imaging Market, By Application
9 Competitive Landscape
9.1 Overview 64
9.2 Competitive Benchmarking 65
9.3 Leading Players In Terms Of Number Of Developments In The Perfusion Imaging Market 66
9.4 Key Development Analysis 67
9.4.1 Partnership/Strategic Agreement 67
9.4.2 Acquisition 68
9.4.3 Product Approval 68
9.4.4 Expansion 68
10 Company Profiles
10.1 General Electric Company 69
10.1.1 Company Overview 69
10.1.2 Financial Overview 69
10.1.3 Products/Services Offered 70
10.1.4 Key Developments 70
10.1.5 SWOT Analysis 70
10.1.6 Key Strategies 71
10.2 Siemens 72
10.2.1 Company Overview 72
10.2.2 Financial Overview 72
10.2.3 Products/Services Offered 73
10.2.4 Key Developments 73
10.2.5 SWOT Analysis 74
10.2.6 Key Strategies 74
10.3 Medtronic 75
10.3.1 Company Overview 75
10.3.2 Financial Overview 75
10.3.3 Products/Services Offered 75
10.3.4 Key Developments 76
10.3.5 SWOT Analysis 76
10.3.6 Key Strategies 76
10.4 Canon Medical Systems Corporation 77
10.4.1 Company Overview 77
10.4.2 Financial Overview 77
10.4.3 Products/Services Offered 78
10.4.4 Key Developments 78
10.4.5 SWOT Analysis 79
10.4.6 Key Strategies 79
10.5 Bracco Diagnostic, Inc. 80
10.5.1 Company Overview 80
10.5.2 Financial Overview 80
10.5.3 Products/Services Offered 81
10.5.4 Key Developments 81
10.5.5 SWOT Analysis 81
10.5.6 Key Strategies 81
10.6 Koninklijke Philips NV 82
10.6.1 Company Overview 82
10.6.2 Financial Overview 82
10.6.3 Products/Services Offered 83
10.6.4 Key Developments 84
10.6.5 SWOT Analysis 84
10.6.6 Key Strategies 84
10.7 Neusoft Corporation 85
10.7.1 Company Overview 85
10.7.2 Financial Overview 85
10.7.3 Products/Services Offered 86
10.7.4 Key Developments 86
10.7.5 SWOT Analysis 86
10.7.6 Key Strategies 86
10.8 Lantheus Medical Imaging, Inc. 87
10.8.1 Company Overview 87
10.8.2 Financial Overview 87
10.8.3 Products/Services Offered 88
10.8.4 Key Developments 88
10.8.5 SWOT Analysis 88
10.8.6 Key Strategies 88
10.9 Shimadzu Corporation 89
10.9.1 Company Overview 89
10.9.2 Financial Overview 89
10.9.3 Products/Services Offered 90
10.9.4 Key Developments 90
10.9.5 SWOT Analysis 90
10.9.6 Key Strategies 90
10.10 Aetna 91
10.10.1 Company Overview 91
10.10.2 Financial Overview 91
10.10.3 Products/Services Offered 92
10.10.4 Key Developments 92
10.10.5 SWOT Analysis 92
10.10.6 Key Strategies 92
10.11 Perimed 93
10.11.1 Company Overview 93
10.11.2 Financial Overview 93
10.11.3 Products/Services Offered 93
10.11.4 Key Developments 93
10.11.5 SWOT Analysis 93
10.11.6 Key Strategies 94
10.12 Advantis Medical Imaging 95
10.12.1 Company Overview 95
10.12.2 Financial Overview 95
10.12.3 Products/Services Offered 95
10.12.4 Key Developments 95
10.12.5 SWOT Analysis 95
10.12.6 Key Strategies 96
11 Appendix
11.1 References 97
11.2 Related Reports 97
12 List Of Tables
TABLE 1 PRIMARY INTERVIEWS 16
TABLE 2 GLOBAL HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 32
TABLE 3 AMERICAS HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 33
TABLE 4 NORTH AMERICA HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 33
TABLE 5 EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 34
TABLE 6 WESTERN EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 34
TABLE 7 ASIA-PACIFIC: HEMP BASED PRODUCTS MARKET, BY COUNTRY 2020–2027 (USD MILLION) 35
TABLE 8 REST OF THE WORLD (ROW) HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 35
TABLE 9 GLOBAL HEMP BASED PRODUCTS MARKET , BY INDUSTRIAL APPLICATION, 2020–2027 (USD MILLION) 36
TABLE 10 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2020–2027 (USD MILLION) 37
TABLE 11 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2020–2028 (VOLUME) 38
TABLE 12 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2019–2027 (VOLUME) 38
TABLE 13 GLOBAL CBD OIL MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 40
TABLE 14 GLOBAL CBD OIL MARKET, FOR MARIJUANA-DERIVED CBD OIL BY REGION, 2020–2027 (USD MILLION) 41
TABLE 15 GLOBAL CBD OIL MARKET, FOR HEMP-DERIVED CBD OIL BY REGION, 2020–2027 (USD MILLION) 42
TABLE 16 GLOBAL CBD OIL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 44
TABLE 17 GLOBAL CBD OIL MARKET, FOR PAIN RELIEF BY REGION, 2020–2027 (USD MILLION) 45
TABLE 18 GLOBAL CBD OIL MARKET, FOR NEUROLOGICAL DISORDERS BY REGION, 2020–2027 (USD MILLION) 46
TABLE 19 GLOBAL CBD OIL MARKET, FOR FIBROMYALGIA BY REGION, 2020–2027 (USD MILLION) 46
TABLE 20 GLOBAL CBD OIL MARKET, FOR MOOD DISORDERS BY REGION, 2020–2027 (USD MILLION) 47
TABLE 21 GLOBAL CBD OIL MARKET, FOR DIABETES BY REGION, 2020–2027 (USD MILLION) 47
TABLE 22 GLOBAL CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 49
TABLE 23 GLOBAL CBD OIL MARKET, FOR E-COMMERCE WEBSITES BY REGION 2020–2027 (USD MILLION) 50
TABLE 24 GLOBAL CBD OIL MARKET, FOR RETAIL PHARMACIES BY REGION 2020–2027 (USD MILLION) 50
TABLE 25 GLOBAL CBD OIL MARKET, FOR MEDICAL MARIJUANA DISPENSARIES BY REGION 2020–2027 (USD MILLION 51
TABLE 26 GLOBAL CBD OIL MARKET, FOR HOSPITAL PHARMACIES BY REGION 2020–2027 (USD MILLION 51
TABLE 27 GLOBAL CBD OIL MARKET, BY REGION 2020–2027 (USD MILLION) 54
TABLE 28 AMERICAS: CBD OIL MARKET, BY REGION 2020–2027 (USD MILLION) 55
TABLE 29 AMERICAS: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 55
TABLE 30 AMERICAS: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 56
TABLE 31 AMERICAS: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 56
TABLE 32 NORTH AMERICA: CBD OIL MARKET, BY COUNTRY 2020–2027 (USD MILLION) 57
TABLE 33 NORTH AMERICA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 57
TABLE 34 NORTH AMERICA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 58
TABLE 35 NORTH AMERICA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 58
TABLE 36 US: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 59
TABLE 37 US: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 59
TABLE 38 US: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 60
TABLE 39 CANADA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 60
TABLE 40 CANADA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 61
TABLE 41 CANADA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 61
TABLE 42 SOUTH AMERICA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 62
TABLE 43 SOUTH AMERICA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 62
TABLE 44 SOUTH AMERICA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 63
TABLE 45 EUROPE: CBD OIL MARKET, BY REGION 2020–2027 (USD MILLION) 64
TABLE 46 EUROPE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 64
TABLE 47 EUROPE: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 65
TABLE 48 EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 65
TABLE 49 WESTERN EUROPE: CBD OIL MARKET, BY COUNTRY 2020–2027 (USD MILLION) 66
TABLE 50 WESTERN EUROPE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 67
TABLE 51 WESTERN EUROPE CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 67
TABLE 52 WESTERN EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 68
TABLE 53 GERMANY: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 69
TABLE 54 GERMANY: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 69
TABLE 55 GERMANY: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 70
TABLE 56 UK: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 70
TABLE 57 UK: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 71
TABLE 58 UK: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 71
TABLE 59 FRANCE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 72
TABLE 60 FRANCE: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 72
TABLE 61 FRANCE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 73
TABLE 62 SPAIN: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 73
TABLE 63 SPAIN: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 74
TABLE 64 SPAIN: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 74
TABLE 65 ITALY: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 75
TABLE 66 ITALY: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 75
TABLE 67 ITALY: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 76
TABLE 68 REST OF WESTERN EUROPE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 76
TABLE 69 REST OF WESTERN EUROPE: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 77
TABLE 70 REST OF WESTERN EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 77
TABLE 71 EASTERN EUROPE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 78
TABLE 72 EASTERN EUROPE: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 78
TABLE 73 EASTERN EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 79
TABLE 74 ASIA-PACIFIC: CBD OIL MARKET, BY COUNTRY 2020–2027 (USD MILLION) 80
TABLE 75 ASIA-PACIFIC: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 81
TABLE 76 ASIA-PACIFIC: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 81
TABLE 77 ASIA-PACIFIC: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 82
TABLE 78 JAPAN: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 82
TABLE 79 JAPAN: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 83
TABLE 80 JAPAN: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 83
TABLE 81 CHINA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 84
TABLE 82 CHINA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 84
TABLE 83 CHINA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 85
TABLE 84 AUSTRALIA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 85
TABLE 85 AUSTRALIA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 86
TABLE 86 AUSTRALIA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 86
TABLE 87 INDIA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 87
TABLE 88 INDIA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 87
TABLE 89 INDIA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 88
TABLE 90 SOUTH KOREA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 89
TABLE 91 SOUTH KOREA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 89
TABLE 92 SOUTH KOREA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 90
TABLE 93 REST OF ASIA-PACIFIC: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 90
TABLE 94 REST OF ASIA-PACIFIC: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 91
TABLE 95 REST OF ASIA-PACIFIC: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 91
TABLE 96 REST OF THE WORLD: CBD OIL MARKET, BY REGION 2020–2027 (USD MILLION) 92
TABLE 97 REST OF THE WORLD: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 92
TABLE 98 REST OF THE WORLD: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 93
TABLE 99 REST OF THE WORLD: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 93
13 List Of Figures
FIGURE 1 GLOBAL CBD OIL MARKET: MARKET STRUCTURE 14
FIGURE 2 RESEARCH PROCESS 16
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 19
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF GLOBAL CBD OIL MARKET 21
FIGURE 5 VALUE CHAIN: GLOBAL CBD OIL MARKET 26
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CBD OIL MARKET 27
FIGURE 7 GLOBAL HEMP BASED PRODUCTS MARKET, BY INDUSTRIAL APPLICATION, 2020 (%) 31
FIGURE 8 GLOBAL HEMP BASED PRODUCTS MARKET, BY HEMP CBD PRODUCT TYPE, 2020 (%) 31
FIGURE 9 GLOBAL HEMP BASED PRODUCTS MARKET, BY REGION, 2020 & 2027 (USD MILLION) 32
FIGURE 10 GLOBAL HEMP BASED PRODUCTS MARKET, BY INDUSTRIAL APPLICATION, 2020 & 2027 (USD MILLION) 36
FIGURE 11 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2020 & 2027 (USD MILLION) 37
FIGURE 12 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2020 & 2027 (VOLUME) 38
FIGURE 13 GLOBAL CBD OIL MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 41
FIGURE 14 GLOBAL CBD OIL MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 45
FIGURE 15 GLOBAL CBD OIL MARKET, BY DISTRIBUTION CHANNEL, 2020 & 2027 (USD MILLION) 49
FIGURE 16 GLOBAL CBD OIL MARKET, BY REGION 2020 & 2027 (USD MILLION) 54
FIGURE 17 AMERICAS: CBD OIL MARKET SHARE, BY REGION 2020 55
FIGURE 18 NORTH AMERICA: CBD OIL MARKET SHARE, BY COUNTRY 2020 57
FIGURE 19 EUROPE: CBD OIL MARKET SHARE, BY REGION 2020 64
FIGURE 20 WESTERN EUROPE: CBD OIL MARKET SHARE, BY COUNTRY 2020 66
FIGURE 21 ASIA-PACIFIC: CBD OIL MARKET SHARE, BY COUNTRY 2020 80
FIGURE 22 REST OF THE WORLD: CBD OIL MARKET SHARE, BY REGION 2020 92
FIGURE 23 GLOBAL CBD OIL MARKET SHARE ANALYSIS, 2020 (%) 95
$7,745.57 Million
6.34%
North America
2022-2030
灌流イメージング市場の概要:
灌流放射線科の市場規模は、2024年までに7,745.57万米ドルに達するには、6.34%のCAGRを登録する必要があります。灌流画像市場調査レポートは、血液が臓器または組織をどのように通過するかを示す目立たない画像検査です。このテストは、さまざまな定常問題の発見に利用されます。
心筋灌流イメージングは、血液が臓器や組織をどのように移動するかを示す目立たない画像検査です。このテストは、さまざまな持続的な問題の発見に利用されます。心血管疾患および神経疾患の蔓延を発展させ、老人人口を拡大することで、世界的な灌流イメージング市場調査レポートの開発が推進されています。たとえば、米国心臓協会統計委員会と脳卒中統計小委員会によると、2017年に一貫して米国では約795,000人が脳卒中を起こし、約610,000人が最初または新しく、185, 000人が断続的な脳卒中です。また、イノベーションの進歩は、市場の発展をさらに満たしています。
心血管感染症および神経感染症を発症し、高齢者の人口を拡大することは、世界的な灌流放射線市場規模の進歩を推進しています。医用画像業界の統計によると、一貫して、米国では約795,000人の個人がヒットしており、そのうち約610,000人が最初または新しく、185, 000人が反復的なストロークです。さらに、イノベーションの進展は、ビジネスセクターの発展をさらに活性化させています。2019年1月、島津製作所は、北米における医療サービス事業を改善するために、コア・メディカル・イメージング社を買収しました。この買収は、北米市場における組織の牽引力を支えました。2018年3月、GEはカナダ保健省から3.0T MRIフレームワークであるSigna Premierの承認を得ました。これにより、心筋灌流イメージング組織のアイテム配置が拡大しました。オーストラリアは、2018年にアジア太平洋灌流画像市場で11.2%の一部を占めました。さらに、中東およびアフリカの市場は、地区の病気に対するマインドフルネスの拡大に一貫して起因するようになることが求められています。
COVID-19分析:
COVID-19のパンデミックは、さまざまなレベルで世界経済に深刻な影響を及ぼし、心筋灌流イメージングビジネスの側面で見ることができます。医療サービスの革新的な仕事の繁栄しているビジネスセクターは、組立ユニットの閉鎖、原材料の在庫の激しい不足、および可能性のある労働の不在から推測できる封鎖時間枠の間に取引の大幅な減少を示す必要があります。パンデミックによって達成された現在の状況から、作成と在庫ネットワークの演習が小さな障害に遭遇したことは非常によく推論されるかもしれません。それにもかかわらず、スペクトの心筋灌流イメージング市場は、COVID-19以降も継続的に回復すると予測されており、まもなく世界のさまざまな地域での取引に魅力的な自由をもたらすでしょう。
市場動態:
灌流イメージングの原動力は、心血管疾患および呼吸器疾患の有病率の増加、臓器移植数の増加、高齢化人口の増加、多臓器不全の発生率の増加、政府とNGO、臓器提供を奨励するイニシアチブ、細胞ベースの研究への投資の増加、および生物学的製造の増加。
Lexiscan心筋灌流イメージングフレームワークは、心血管疾患および呼吸器疾患の患者を注意深く治療するための心肺フレームワークを回避するために利用されています。灌流フレームワーク、例えば、心臓と肺が血液の酸素化の相互作用を完了するのを怠ると、心臓と肺は酸素を運び、患者の二酸化炭素を排除します。
灌流イメージング市場の機会は、新興市場における医薬品研究の増加と連続製造に対する選好の高まりです。
Perfusion Imaging Industry Research Reportによると、製薬開発事業セクターの規模拡大に影響を与える要因は、近くの従来の医薬品のアップセルです。人口の成熟とコストの急速な拡大の結果として、政府はウェルビーイング計画におけるジェネリック医薬品の利用を支援しました。全体として、ジェネリック医薬品はマークされたパーのわずか20%しかかかりませんトナー。
灌流イメージング業界の研究レポートの効果的な抑制は、臓器移植と倫理的懸念の高コスト、および細胞ベースの研究の高コストのようなものです。
灌流画像市場調査レポートによると、米国では臓器移植は非常に高価です。カウンセリング会社のミリマンが示しているように、心臓再配置の通常請求される費用は1,382,400ドルと予想され、異なる臓器はそれほど安くはありません。
灌流イメージング研究報告書によると、主な課題は臓器の需給ギャップです。
60年代後半から現在に至るまで、移転の尺度は徐々に、しかし一貫して拡大してきました。それにもかかわらず、再配置される臓器の関心は非常に高い割合で増加しており、臓器への関心と供給の間に穴が広がっています。
Perfusion Imaging Research Reportによると、心臓病、肝臓、腎臓の感染症などの絶え間ない病気の症例の増加は、定期的に臓器の再配置を促し、世界的な灌流市場の重要な推進力の1つです。その上、不適切な食事ルーチン、喫煙、酒の利用などのさまざまな要因による臓器の失望の事例が高まっているため、説得力のある灌流の枠組みへの関心が高まっています。
世界的なレキシスキャン心筋灌流イメージング市場は一貫して発展しており、推測期間中にその開発を進めることに依存しています。世界規模の灌流放射線市場レポートは、予想期間中にCAGR 4.1%で開発する必要があり、2023年までに約15億2,700万米ドルに達すると評価されています。
テクノロジー分析
イノベーションの進歩は、現在の組織に日々の財政的動きをもたらす多様な利益をもたらしました。灌流イメージング業界の分析によると、組織はより良い計画を立てるために市場開発の例を理解する必要があります。効果的な手順により、組織はアレンジの有利なスタートを切り、候補者よりも優位に立つことができます。
セグメントの概要:
灌流イメージング市場調査レポートは、心肺灌流フレームワーク、細胞灌流フレームワーク、およびex vivo臓器灌流に分かれています。灌流イメージング市場調査レポートフレームワークの部分は、2016年の世界の灌流フレームワーク市場の最大の部分を占めました。この断片の大部分は、心血管および呼吸器感染の優位性の拡大と、世界中の臓器再配置システムの数の増加に起因する可能性があります。
セグメントに基づいて、Perfusion Imaging IndustryResearch Reportは、心肺装置、酸素供給装置、消耗品、血管チャネル、サイフォン、観察フレームワーク、情報ボードフレームワーク、ウォーマークーラー、カニューレ、およびエクストラに細分化されています。オキシジェネーターの断片は、2016年の世界の灌流イメージング市場調査レポートフレームワーク市場の最大の部分を代表するために信頼されています。この断片の膨大な部分は、心肺失望の発生の増加に大きく貢献することができます。
灌流イメージング産業研究レポートは、この方法に基づいて、低体温マシン灌流と正常体温マシン灌流に分類されています。低体温マシン灌流フラグメントは、ex vivo臓器灌流市場の最大の部分を占めていました。このセクションの高度な開発は、低体温の機械灌流の利点に貢献できます。たとえば、長距離の改善は持久力率、血管痙攣の減少、代謝の助けを提供する能力などです。
タイプに基づいて、細胞灌流イメージング市場調査レポートは、バイオリアクター灌流フレームワーク、マイクロ流体灌流フレームワーク、重力またはプレスファクター駆動灌流フレームワーク、および小さな温血動物臓器灌流フレームワークに断片化されています。バイオリアクター灌流フレームワークの断片は、最大のpoを表しています
Report Attribute/Metric | Details |
---|---|
Market Size | USD 7,745.57 Million |
CAGR | 6.34% (2019-2024) |
Base Year | 2019 |
Forecast Period | 2020-2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Modality, Application and Region |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | General Electric Company (US), Advantis Medical Imaging (Netherland) , Aetna (US), lantheus Medical Imaging, Inc. (US), Koninklijke Philips NV (Netherlands), Canon Medical Systems Corporation (Japan), Medtronic (Ireland), Siemens (Germany), Bracco Diagnostic, Inc. (Italy), Neusoft Corporation (China), Shimadzu Corporation (Japan), Perimed (US) |
Key Market Opportunities | Increasing Pharmaceutical Research in Emerging Markets and Rising Preference for Continuous Manufacturing. |
Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Perfusion Imaging Market is projected to grow at a 6.34% CAGR between 2020-2027.
Perfusion Imaging Market predicted to touch USD 7,745.57 million by 2023.
The Americas is expected to dominate the Perfusion Imaging Market.
It finds extensive applications in functional brain imaging, ventilation perfusion imaging, and myocardial perfusion imaging.
Stringent regulatory policies may limit market growth.